Working capital decreased 52.1%
Working capital changed -52.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital changed -52.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed -4.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Trade receivables changed +30.1% from the comparable as-filed period.
Free-cash-flow proxy changed +15.6% from the comparable as-filed period.
Research & development changed +25.7% from the comparable as-filed period.
Cash & equivalents changed -15.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed +16.2% from the comparable as-filed period.
Operating cash flow changed +13.6% from the comparable as-filed period.
Operating income changed +14.7% from the comparable as-filed period.
Net income changed -23.6% from the comparable as-filed period.
Receivables / revenue changed +733 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -17 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +15.8% from the comparable as-filed period.
Gross profit changed +15.0% from the comparable as-filed period.
Working capital / assets changed -796 basis points from the comparable as-filed period.
Operating cash flow / net income changed +48.6% from the comparable as-filed period.
Cost of revenue changed +21.4% from the comparable as-filed period.
Current assets changed -6.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed -57.9% from the comparable as-filed period.
Gross margin changed -80 basis points from the comparable as-filed period.
SBC / revenue changed -179 basis points from the comparable as-filed period.
R&D / revenue changed +186 basis points from the comparable as-filed period.
Stockholders' equity changed -9.2% from the comparable as-filed period.
Capex / revenue changed -100 basis points from the comparable as-filed period.
Current ratio changed -19.6% from the comparable as-filed period.
Operating cash-flow margin changed -127 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +0.7% from the comparable as-filed period.
Free-cash-flow margin changed -28 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +2.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.